Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 35.50
+0.75 (2.16%)
Oct 16, 2026, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.95 billion as of October 16, 2026. It is the 22,509th most valuable company in the world and the 1,110th biggest in Taiwan. Its market cap has increased by 21.58% in one year.
Market Cap
4.95B
Enterprise Value
7.14B
Revenue
1.27B
Global Rank
Country Rank
#1,110 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.95B, an increase of 622.42%. That is a compound annual growth rate of 9.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 4.95B | 9.57% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 7.13B |
| TaiGen Biopharmaceuticals Holdings | 6.38B |
| Sinphar Pharmaceutical | 6.30B |
| Mycenax Biotech | 4.80B |
| BRIM Biotechnology | 4.47B |
| UnicoCell Biomed | 4.43B |
| Sunhawk Vision Biotech | 4.36B |
| Sinew Pharma | 4.26B |